Capital Research Global Investors 13D and 13G filings for Praxis Precision Medicines, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-05-13 11:32 am Sale | 2025-03-31 | 13G | Praxis Precision Medicines, Inc. PRAX | Capital Research Global Investors | 853,746 4.200% | -143,348 (-14.38%) | Filing |
| 2024-11-12 1:29 pm Purchase | 2024-11-07 | 13G | Praxis Precision Medicines, Inc. PRAX | Capital Research Global Investors | 997,094 5.600% | 997,094 (New Position) | Filing |